INTRODUCTION
Thyroid cancer is the most common endocrine malignancy [1] . The incidence of thyroid cancer has increased worldwide, including in Korea [2] . In the United States, the age-adjusted incidence rate increased from 4.9 per 100,000 (3.1 in males, 6.5 in females) to 14.7 per 100,000 (7.4 in males, 21.8 in females) between 1975 and 2011 [3] . According to the Korea National Cancer Incidence Database, crude and age-standardized cancer incidence rates during 2011 were 81.0 per 100,000 (27.9 in males, 134.1 in females) and 58.3 per 100,000 (20.2 in males, 96.8 in females), respectively. The incidence of thyroid cancer was increased by 23.3% per year in both sexes, and since 2009 it has been the most common cancer in women in Korea [4] .
Enhanced detection using high-resolution ultrasonography may have contributed to the increased incidence in thyroid cancer. However, it cannot fully explain the increase, and there seems to be a true increase in thyroid cancer incidence [5, 6] . It is also possible that increases in exposure to some unknown risk factors account for the increase in incidence [7] . Despite the surge in incidence, disease-specific thyroid cancer mortality has reportedly remained stable [8, 9] .
RESULTS
The CMR for thyroid cancer was 0.11 per 100,000 in 1985 and 0.74 per 100,000 in 2010 (Table 2 Fig. 1D ). This ASMR pattern was observed in both sexes.
DISCUSSION
This is the first study to focus on changes in thyroid cancer mortality over a 25-year period in Korea. Using national statistics data, we showed that the ASMR for thyroid cancer increased between 1985 and 2000. However, the ASMR decreased slightly after 2000 in Korea. Changes in thyroid cancer mortality in other countries are inconclusive. A recent global study reported thyroid cancer mortality rates in 2012 of 0.6 per 100,000 in females and 0.3 per 100,000 in males [15] . This result was similar to our ASMR for 2010 determined using the WHO population. According to a SEER cancer statistics review (1975 to 2010), the overall average annual percent change of thyroid cancer mortality was slightly increased by 0.9% between 2001 and 2010 (1.6% in males and 0.9% in females) [6, 16, 17] . However, an European group reported a decrease in thyroid cancer mortality in several countries worldwide (including Republic of Korea), particularly in women [15] .
Recently, the National Cancer Center in Korea reported annual national cancer statistics in Korea [4, 18] . In a recent report, 5-year relative survival rates for all cancer sites were shown for four diagnosis periods: [4] . Survival rates improved in both males and females (from 87.2% to 89.5%, 95.8%, and 100.1% in males and from 95.4% to 95.9%, 98.7%, and 99.9% in females). These findings for thyroid cancer reflect our ASMR analysis for 1985 to 2010.
The reasons for the decrease in ASMR in Korea after 2000 are unclear. The incidence of thyroid cancer in Korea increased rapidly during recent decades. According to Han et al. [19] , the thyroid cancer screening rate in Korea in 2009 was 13.2% (8.4% of men and 16.4% of women). In addition, the use of highresolution ultrasonography may have contributed to the early detection of asymptomatic small thyroid nodules [20] . As a result, the size distribution of detected thyroid cancers has shifted toward smaller lesions [9, 21] . The increasing number of surgically treated cases of thyroid cancer is predominantly due to an Copyright © 2014 Korean Endocrine Society increase in tumors measuring 1 cm or less [22] . Therefore, increased screening of thyroid cancer using neck ultrasonography and treatment during the early stages could be reasons for the recent decrease in thyroid cancer mortality. The standardization of treatment for thyroid cancer could be another reason for these changes. However, at present the exact cause of these changes is not clear. This study has an important limitation: the method used by Statistics Korea to collect data on the cause of death was changed in 1999. Since 1999, the cause of death has been supplemented by external data. It is possible that this change influenced the mortality trend until 2000. However, there has been no change in the data collection method since 1999. The ASMR for thyroid cancer decreased between 2000 and 2010.
In summary, the ASMR for thyroid cancer in Korea increased until 2000 and then decreased slightly between 2000 and 2010 in both sexes.
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